Wei Fang

Addition of BTK inhibitor orelabrutinib to rituximab improved anti-tumor effects in B cell lymphoma

Jun Zhu, Hui Yu, L. Mi, 2021, Molecular therapy oncolytics.

Isolating Rare Cells and Circulating Tumor Cells with High Purity by Sequential eDAR.

Perry G. Schiro, D. Chiu, B. Fujimoto, 2019, Analytical chemistry.

The Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) as a Novel Therapeutic Target in Mantle Cell Lymphoma

Jun Zhu, Hui Yu, L. Mi, 2022, Cancer control : journal of the Moffitt Cancer Center.